CoChat

CDK16 Phosphorylates and Degrades p53 to Promote Radioresistance and Predicts Prognosis in Lung Cancer

Open access
Xie, Jie, Li, Yan, Jiang, Ke, Hu, Kaishun, Zhang, Sheng, Dong, Xiaorong, Dai, Xiaofang, Liu, Li, Zhang, Tao, Yang, Kunyu, Huang, Kai, Chen, Junjie, Shi, Shaojun, Zhang, Yu, Wu, Gang, Xu, Shuangbing · 2018 · Theranostics
Cited by 52

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Abstract

Rationale: Radioresistance is considered the main cause of local relapse in lung cancer.However, the molecular mechanisms of radioresistance remain poorly understood.This study investigates the role of CDK16 in radioresistance of human lung cancer cells.Methods: The expression levels of CDK16 were determined by immunohistochemistry in lung cancer tissues and adjacent normal lung tissues.Immunoprecipitation assay and GST pulldown were utilized to detect the protein-protein interaction.The phosphorylation of p53 was evaluated by in vitro kinase assay.Poly-ubiquitination of p53 was examined by in vivo ubiquitination assay.Cell growth and apoptosis, ROS levels and DNA damage response were measured for functional analyses.Results: We showed that CDK16 is frequently overexpressed in lung cancer cells and tissues, and high levels of CDK16 are correlated with lymph node stage and poor prognosis in lung cancer patients.Furthermore, we provided evidence that CDK16 binds to and phosphorylates p53 at Ser315 site to inhibit transcriptional activity of p53.Moreover, we uncovered that this phosphorylation modification accelerates p53 degradation via the ubiquitin/proteasome pathway.Importantly, we demonstrated that CDK16 promotes radioresistance by suppressing apoptosis and ROS production as well as inhibiting DNA damage response in lung cancer cells in a p53-dependent manner.Conclusion: Our findings suggest that CDK16 negatively modulates p53 signaling pathway to promote radioresistance, and therefore represents a promising therapeutic target for lung cancer radiotherapy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.7150/thno.21963

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Cited by

Metadata

Authors
Xie, J., Li, Y., Jiang, K., Hu, K., Zhang, S., Dong, X., Dai, X., Liu, L., Zhang, T., Yang, K., Huang, K., Chen, J., Shi, S., Zhang, Y., Wu, G., & Xu, S.
Venue
Theranostics
Published
2018
Volume
8
Issue
3
Pages
650-662
ISSN
1838-7640 (ISSN-L)
OpenAlex
W2771018599
Cited by
52
References
9
FWCI
1.40
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.